Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study.

Španiel F, Hrdlička J, Novák T, Kožený J, Höschl C, Mohr P, Motlová LB.

J Psychiatr Pract. 2012 Jul;18(4):269-80. doi: 10.1097/01.pra.0000416017.45591.c1.

PMID:
22805901
2.

Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system.

Spaniel F, Novak T, Bankovska Motlova L, Capkova J, Slovakova A, Trancik P, Matejka M, Höschl C.

J Psychiatr Ment Health Nurs. 2015 Dec;22(10):811-20. doi: 10.1111/jpm.12251. Epub 2015 Jul 14.

PMID:
26176646
3.

Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: a randomized controlled trial.

Komatsu H, Sekine Y, Okamura N, Kanahara N, Okita K, Matsubara S, Hirata T, Komiyama T, Watanabe H, Minabe Y, Iyo M.

Schizophr Res. 2013 Oct;150(1):240-4. doi: 10.1016/j.schres.2013.08.007. Epub 2013 Aug 31.

4.

ITAREPS: information technology aided relapse prevention programme in schizophrenia.

Spaniel F, Vohlídka P, Hrdlicka J, Kozený J, Novák T, Motlová L, Cermák J, Bednarík J, Novák D, Höschl C.

Schizophr Res. 2008 Jan;98(1-3):312-7. Epub 2007 Oct 24.

PMID:
17920245
5.

The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up.

Spaniel F, Vohlídka P, Kozený J, Novák T, Hrdlicka J, Motlová L, Cermák J, Höschl C.

Int J Clin Pract. 2008 Dec;62(12):1943-6. doi: 10.1111/j.1742-1241.2008.01903.x. Epub 2008 Sep 13.

6.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004718. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD004718.

PMID:
17054213
7.

Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.

Citrome L, Meng X, Hochfeld M, Stahl SM.

Hum Psychopharmacol. 2012 Jan;27(1):24-32. doi: 10.1002/hup.1254. Epub 2011 Dec 7.

PMID:
22161738
8.

Schizophrenia prediction with the adaboost algorithm.

Hrdlicka J, Klema J.

Stud Health Technol Inform. 2011;169:574-8.

PMID:
21893814
9.

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.

Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM.

J Clin Psychiatry. 2006 Aug;67(8):1194-203.

PMID:
16965196
10.

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.

Csernansky JG, Mahmoud R, Brenner R; Risperidone-USA-79 Study Group.

N Engl J Med. 2002 Jan 3;346(1):16-22. Erratum in: N Engl J Med 2002 May 2;346(18):1424.

11.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
12.

[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].

Misdrahi D, Delgado A, Bouju S, Comet D, Chiariny JF.

Encephale. 2013 May;39 Suppl 1:S8-14. doi: 10.1016/j.encep.2012.03.005. Epub 2013 Mar 28. French.

PMID:
23541914
13.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
14.

A program for relapse prevention in schizophrenia: a controlled study.

Herz MI, Lamberti JS, Mintz J, Scott R, O'Dell SP, McCartan L, Nix G.

Arch Gen Psychiatry. 2000 Mar;57(3):277-83.

PMID:
10711914
15.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
16.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
17.

A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP.

J Clin Psychiatry. 2012 May;73(5):654-60. doi: 10.4088/JCP.11m07522. Erratum in: J Clin Psychiatry. 2012 Jul;73(7):1035.

PMID:
22697191
18.

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Olivares JM, Rodriguez-Martinez A, Burón JA, Alonso-Escolano D, Rodriguez-Morales A; e-STAR Study Group.

Appl Health Econ Health Policy. 2008;6(1):41-53.

PMID:
18774869
19.

Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.

Bender S, Olbrich HM, Fischer W, Hornstein C, Schoene W, Falkai P, Haarmann C, Berger M, Gastpar M; Trimipramine Study Group.

Pharmacopsychiatry. 2003 Mar-Apr;36(2):61-9.

PMID:
12734763
20.

Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial.

UK Dermatology Clinical Trials Network’s PATCH Trial Team, Thomas K, Crook A, Foster K, Mason J, Chalmers J, Bourke J, Ferguson A, Level N, Nunn A, Williams H.

Br J Dermatol. 2012 Jan;166(1):169-78. doi: 10.1111/j.1365-2133.2011.10586.x. Epub 2011 Dec 6.

Supplemental Content

Support Center